Heart attacks claim the lives of many people each year. Poor food and lifestyle choices are the main cause of this. Nevertheless, a low-cost and efficient method of avoiding this has also been found.
Early Heart Attack Prevention: Although heart attacks can happen at any time, they can be avoided by taking preventive measures. According to a recent study, there is a low-cost and efficient method of preventing heart attacks, particularly for people who have already experienced one. According to this study, ezetimibe and statins, two inexpensive medications, can greatly lower the chance of having a heart attack and prevent one from happening again.

What is the conclusion of the research?
After analyzing data from over 36,000 cardiac patients, researchers from Lund University in Sweden and Imperial College in London discovered that these medications can be quite successful at preventing heart attacks if taken on schedule. Most importantly, the risk of heart attacks can be considerably decreased by controlling cholesterol beforehand.
The significance of early therapy
The body enters a sensitive state following a heart attack, where the arteries weaken and the chance of having another heart attack rises. Nevertheless, many individuals do not receive cholesterol-lowering medications right away. The doctors’ current approach is “wait and watch,” wherein one medication is administered first, followed by additional medications based on need; however, delaying medication can have negative consequences.
Ezetimibe with statin combination
Heart disease is already treated with statins. They lower the liver’s cholesterol levels, particularly the harmful LDL cholesterol. Conversely, ezetimibe prevents the intestines from absorbing cholesterol. Together, the two medications efficiently and rapidly lower cholesterol.

What this investigation discovered
Researchers from Sweden and the UK examined heart attack survivors in their study. Three groups—those taking ezetimibe later, those using statins alone, and those taking both medications within 12 weeks of the heart attack—were compared. According to the findings, patients who started the combination medication early had a lower death rate, a lower chance of having another heart attack, and fewer heart issues down the road.
Medicines that are accessible and reasonably priced
The survey also discovered that both of these medications are inexpensive and already available in the majority of nations. Ezetimibe has fewer adverse effects and is less expensive. However, in the early stages of treatment, it is frequently ignored.
Read More: India’s First Train With ATM Onboard! No Cash Worries

Join Our Group For All Information And Update, Also Follow me For Latest Information | |
Facebook Page | Click Here |
Click Here | |
Click Here |